🔎
ailternative

Best Bright Pink Risk Assessment Alternatives ranked by AI · updated Aug 2026

Bright Pink's risk assessment resources help people evaluate breast and ovarian cancer risk and prepare for conversations with healthcare professionals. They are designed for public education and personal risk awareness rather than full clinical genetic modeling.

Developer: Bright Pink Price: Free 🎯 brightpink.org
🏥 Healthcare patient education cancer risk breast cancer ovarian cancer

Top 6 Bright Pink Risk Assessment alternatives

1 iPrevent logo

iPrevent

Peter MacCallum Cancer Centre

iPrevent is a web-based hereditary cancer risk assessment and management tool for healthcare professionals and patients. It estimates cancer and gene-mutation risks...

Pros

  • Combines risk estimation with personalized management recommendations
  • Designed for hereditary breast, ovarian and related cancer assessment
  • Supports clinician-patient discussions and referral decisions

Cons

  • More specialized to hereditary cancer than general cancer risk tools
  • Australian clinical guidance may not match recommendations in every country
  • Requires detailed personal and family history for useful results

Free

Alternatives to iPrevent → Visit site
2

CanRisk

CanRisk Consortium and University of Cambridge

CanRisk is a web-based cancer risk assessment tool for genetics professionals and researchers. It combines family history, genetic variants and personal risk...

Pros

  • Broader cancer coverage than iPrevent
  • Uses detailed family-history and genetic information
  • Provides clinically oriented risk estimates for multiple cancers

Cons

  • More complex to configure than iPrevent
  • Primarily designed for trained professionals
  • Requires substantial data for reliable estimates

Free

Alternatives to CanRisk → Visit site
3

ASK2ME

Dana-Farber Cancer Institute

ASK2ME is an online risk-management tool for people with hereditary cancer-predisposition gene variants. It estimates age-specific cancer risks and summarizes gene-specific screening...

Pros

  • Covers many hereditary cancer genes and syndromes
  • Presents age-specific risk estimates
  • Useful for counseling patients after genetic testing

Cons

  • Requires a known or suspected pathogenic gene variant
  • Does not replace a full family-history risk assessment
  • Recommendations need interpretation by genetics professionals

Free

Alternatives to ASK2ME → Visit site
4

IBIS Breast Cancer Risk Evaluation Tool

IBIS Research Group

The IBIS Breast Cancer Risk Evaluation Tool, also known as the Tyrer-Cuzick model, estimates a woman's likelihood of developing breast cancer. It...

Pros

  • Widely used for individualized breast cancer risk estimation
  • Includes breast density and extensive reproductive factors
  • Often better suited than basic calculators for screening stratification

Cons

  • Focused mainly on breast cancer rather than multiple hereditary cancers
  • Less useful for ovarian, pancreatic or colorectal risk planning
  • Advanced versions may require licensed clinical software

Free for eligible use; licensing may apply

Alternatives to IBIS Breast Cancer... → Visit site
5

NCI Breast Cancer Risk Assessment Tool

National Cancer Institute

The NCI Breast Cancer Risk Assessment Tool is a public calculator based on the Gail model. It estimates a woman's five-year and...

Pros

  • Simple, publicly accessible breast cancer risk estimate
  • Backed by the U.S. National Cancer Institute
  • Useful for initial population-level risk discussions

Cons

  • Less comprehensive for hereditary family-history assessment
  • Does not model most inherited gene variants
  • Limited to breast cancer and selected risk factors

Free

Alternatives to NCI Breast Cancer... → Visit site
6

CancerIQ

CancerIQ

CancerIQ is a clinical software platform for identifying, assessing and managing patients at elevated hereditary cancer risk. It supports risk questionnaires, genetic...

Pros

  • More complete clinical workflow support than iPrevent
  • Integrates risk assessment with genetic testing and patient navigation
  • Designed for health systems and multidisciplinary care teams

Cons

  • Enterprise procurement is less accessible than iPrevent
  • Pricing is not publicly listed
  • Implementation and staff training may be substantial

N/A

Alternatives to CancerIQ → Visit site

How good are these alternatives?

Your feedback helps us improve the AI rankings.

✅ Thanks for your feedback!

Know a better alternative? 🙌

Suggest a product and our AI will verify it's a real alternative to Bright Pink Risk Assessment before adding it to the list.